Dann Stephen G, Ryskin Michael, Barsotti Anthony M, Golas Jonathon, Shi Celine, Miranda Miriam, Hosselet Christine, Lemon Luanna, Lucas Judy, Karnoub Maha, Wang Fang, Myers Jeremy S, Garza Scott J, Follettie Maximillian T, Geles Kenneth G, Klippel Anke, Rollins Robert A, Fantin Valeria R
Pfizer Oncology Research Unit, San Diego, CA, USA
Pfizer Oncology Research Unit, Pearl River, NY, USA.
EMBO J. 2015 Jul 2;34(13):1773-85. doi: 10.15252/embj.201488166. Epub 2015 May 15.
Lat1 (SLC7A5) is an amino acid transporter often required for tumor cell import of essential amino acids (AA) including Methionine (Met). Met is the obligate precursor of S-adenosylmethionine (SAM), the methyl donor utilized by all methyltransferases including the polycomb repressor complex (PRC2)-specific EZH2. Cell populations sorted for surface Lat1 exhibit activated EZH2, enrichment for Met-cycle intermediates, and aggressive tumor growth in mice. In agreement, EZH2 and Lat1 expression are co-regulated in models of cancer cell differentiation and co-expression is observed at the invasive front of human lung tumors. EZH2 knockdown or small-molecule inhibition leads to de-repression of RXRα resulting in reduced Lat1 expression. Our results describe a Lat1-EZH2 positive feedback loop illustrated by AA depletion or Lat1 knockdown resulting in SAM reduction and concomitant reduction in EZH2 activity. shRNA-mediated knockdown of Lat1 results in tumor growth inhibition and points to Lat1 as a potential therapeutic target.
Lat1(SLC7A5)是一种氨基酸转运蛋白,肿瘤细胞摄取包括蛋氨酸(Met)在内的必需氨基酸(AA)时通常需要它。Met是S-腺苷甲硫氨酸(SAM)的必需前体,SAM是包括多梳抑制复合物(PRC2)特异性EZH2在内的所有甲基转移酶所利用的甲基供体。通过表面Lat1分选的细胞群体表现出EZH2激活、Met循环中间体富集以及小鼠体内肿瘤的侵袭性生长。与此一致的是,在癌细胞分化模型中EZH2和Lat1的表达共同受到调控,并且在人肺肿瘤的侵袭前沿观察到二者共表达。EZH2基因敲除或小分子抑制导致RXRα去抑制,从而使Lat1表达降低。我们的结果描述了一个Lat1-EZH2正反馈回路,表现为AA耗竭或Lat1基因敲除导致SAM减少,同时EZH2活性降低。shRNA介导的Lat1基因敲除导致肿瘤生长受到抑制,并表明Lat1是一个潜在的治疗靶点。